Lixte Biotechnology Stock Forecast - Double Exponential Smoothing
| LIXT Stock | USD 3.47 0.12 3.58% |
The Double Exponential Smoothing forecasted value of Lixte Biotechnology Holdings on the next trading day is expected to be 3.49 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 8.94. Lixte Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Lixte Biotechnology stock prices and determine the direction of Lixte Biotechnology Holdings's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Lixte Biotechnology's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Lixte Biotechnology's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Lixte Biotechnology's systematic risk associated with finding meaningful patterns of Lixte Biotechnology fundamentals over time.
Check out Historical Fundamental Analysis of Lixte Biotechnology to cross-verify your projections. Lixte |
Most investors in Lixte Biotechnology cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Lixte Biotechnology's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Lixte Biotechnology's price structures and extracts relationships that further increase the generated results' accuracy.
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for Lixte Biotechnology works best with periods where there are trends or seasonality. Lixte Biotechnology Double Exponential Smoothing Price Forecast For the 20th of April
Given 90 days horizon, the Double Exponential Smoothing forecasted value of Lixte Biotechnology Holdings on the next trading day is expected to be 3.49 with a mean absolute deviation of 0.15, mean absolute percentage error of 0.06, and the sum of the absolute errors of 8.94.Please note that although there have been many attempts to predict Lixte Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Lixte Biotechnology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Lixte Biotechnology Stock Forecast Pattern
| Backtest Lixte Biotechnology | Lixte Biotechnology Price Prediction | Buy or Sell Advice |
Lixte Biotechnology Forecasted Value
In the context of forecasting Lixte Biotechnology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Lixte Biotechnology's downside and upside margins for the forecasting period are 0.03 and 12.78, respectively. We have considered Lixte Biotechnology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Lixte Biotechnology stock data series using in forecasting. Note that when a statistical model is used to represent Lixte Biotechnology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.037 |
| MAD | Mean absolute deviation | 0.1515 |
| MAPE | Mean absolute percentage error | 0.0566 |
| SAE | Sum of the absolute errors | 8.936 |
Predictive Modules for Lixte Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lixte Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lixte Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Lixte Biotechnology
For every potential investor in Lixte, whether a beginner or expert, Lixte Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Lixte Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Lixte. Basic forecasting techniques help filter out the noise by identifying Lixte Biotechnology's price trends.Lixte Biotechnology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lixte Biotechnology stock to make a market-neutral strategy. Peer analysis of Lixte Biotechnology could also be used in its relative valuation, which is a method of valuing Lixte Biotechnology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Lixte Biotechnology Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Lixte Biotechnology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Lixte Biotechnology's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Lixte Biotechnology Market Strength Events
Market strength indicators help investors to evaluate how Lixte Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lixte Biotechnology shares will generate the highest return on investment. By undertsting and applying Lixte Biotechnology stock market strength indicators, traders can identify Lixte Biotechnology Holdings entry and exit signals to maximize returns.
| Accumulation Distribution | 662.86 | |||
| Daily Balance Of Power | 0.5714 | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 3.44 | |||
| Day Typical Price | 3.45 | |||
| Price Action Indicator | 0.095 | |||
| Period Momentum Indicator | 0.12 |
Lixte Biotechnology Risk Indicators
The analysis of Lixte Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lixte Biotechnology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lixte stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.49 | |||
| Semi Deviation | 4.98 | |||
| Standard Deviation | 9.53 | |||
| Variance | 90.86 | |||
| Downside Variance | 37.13 | |||
| Semi Variance | 24.76 | |||
| Expected Short fall | (6.68) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Lixte Biotechnology to cross-verify your projections. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Lixte Stock analysis
When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Lixte Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lixte Biotechnology. If investors know Lixte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lixte Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.66) | Return On Assets (0.64) | Return On Equity (1.11) |
The market value of Lixte Biotechnology is measured differently than its book value, which is the value of Lixte that is recorded on the company's balance sheet. Investors also form their own opinion of Lixte Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Lixte Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lixte Biotechnology's market value can be influenced by many factors that don't directly affect Lixte Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lixte Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lixte Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lixte Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.